Trial Profile
Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2020
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 21 Aug 2013 New trial record